Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women.

MLA

Menes, Tehillah S., et al. “Clinical Breast Exam Contribution to Breast Cancer Diagnosis in BRCA Mutation Carriers vs. Average to Intermediate Risk Women.” Breast Cancer Research and Treatment, vol. 207, no. 1, Aug. 2024, pp. 111–18. EBSCOhost, https://doi.org/10.1007/s10549-024-07345-3.

APA

Menes, T. S., Zippel, D., Sklair-Levy, M., Friedman, E., Bernstein-Molho, R., Faermann, R., & Madorsky Feldman, D. (2024). Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women. Breast Cancer Research and Treatment, 207(1), 111–118. https://doi.org/10.1007/s10549-024-07345-3

Chicago

Menes, Tehillah S, Douglas Zippel, Miri Sklair-Levy, Eitan Friedman, Rinat Bernstein-Molho, Renata Faermann, and Dana Madorsky Feldman. 2024. “Clinical Breast Exam Contribution to Breast Cancer Diagnosis in BRCA Mutation Carriers vs. Average to Intermediate Risk Women.” Breast Cancer Research and Treatment 207 (1): 111–18. doi:10.1007/s10549-024-07345-3.